It’s about patients. At Linton, we believe everyone should have the opportunity to live their best years. Whether it’s having more time to spend with their loved ones, working more on their passion projects, or having the mobility to enjoy.
That’s why we as bioprinting pioneers
look to use advanced chemistry and robotics to biofabricate bioprinted vascular grafts that allow patients to do more, more of what they love.
Bioprinting Pioneers
Ricky Solorzano
CEO
Julio Aleman, Ph.D.
CTO
Y. Shrike Zhang, Ph.D.
VP of Science
Adam Jakus, Ph.D.
BioFab Advisor
leaders
in vascular CARE
It takes a team. And Linton, has on boarded a team of experts who really care about bringing to market products that makes a difference in patients’ lives. From patient perspectives, regulatory approvals, to commercialization strategy, the team is an amazing group of individuals ready to help bridge the innovation of bioprinting to the benefit of vascular care.
vascular device experts
C. Keith Ozaki, M.D.
Vascular Innovator
John Ross, M.D.
AV Access Expert
Terry Litchfield
Reimbursement Navigator
Robert Lee, M.D.
Former FDA Officer
Geoffrey Beecher
Commercialization Strategist
Powerful,
easy-to-use Grafts
That last
It has to be innovative. With the ability to infuse both synthetic and human biomaterials into a single graft using bioprinting, we look to fabricate grafts that integrate well in the body, yet have resiliency for the demands of life, to allow for high patency, ease of cannulation, and infection resistance.
backed by those with vision
join us.
Interested in working together?
Or Subscribing?
Fill out the form.
We look forward to hearing from you.